Key result
Early ECMO and immunosuppression rescue fulminant eosinophilic myocarditis, restoring LVEF to 50%.
Why the study?
Eosinophilic myocarditis is a rare inflammatory cardiomyopathy with variable presentation and diagnostic challenges requiring biopsy and early immunosuppression and mechanical support in severe cases.
Case Report (n=1)
No
Early initiation of mechanical circulatory support and immunosuppressive therapy can lead to favorable outcomes in fulminant eosinophilic myocarditis despite severe systemic complications.
May support early ECMO plus immunosuppression in fulminant eosinophilic myocarditis; hypothesis-generating and requires prospective validation.
Eosinophilic myocarditis (EM) is a rare inflammatory cardiomyopathy with a highly variable clinical presentation, ranging from mild symptoms to fulminant cardiogenic shock. Its diagnosis is challenging due to non-specific clinical findings and requires a high index of suspicion, with endomyocardial biopsy (EMB) serving as the gold standard. Early initiation of immunosuppressive therapy and, in severe cases, mechanical circulatory support (MCS) are essential to improve outcomes. We report the case of a 21-year-old male who presented with progressive dyspnea, chest pain, and hypoxemia. Echocardiography revealed severe left ventricular dysfunction. Coronary angiography excluded obstructive disease, while EMB confirmed EM. Due to cardiogenic shock, veno-arterial extracorporeal membrane oxygenation (ECMO) was implanted on the day of admission. High-dose corticosteroids and azathioprine were initiated, leading to gradual improvement of ventricular function and subsequent ECMO explantation. The course was complicated by left ventricular thrombus formation, which resolved under systemic anticoagulation, and by ischemic colitis requiring right hemicolectomy with ileostomy. Following tracheostomy and prolonged weaning, the patient achieved functional recovery and was discharged on immunosuppressive and anticoagulant therapy. Six months later, surgical restoration of bowel continuity was performed without complications. Follow-up echocardiography demonstrated recovery of left ventricular ejection fraction (LVEF) to 50%, with no evidence of thrombus recurrence. This case highlights the diagnostic and therapeutic challenges of EM, including its fulminant presentation, life-threatening complications, and the critical role of multidisciplinary management. Prompt recognition, biopsy-guided diagnosis, early immunosuppression, MCS when indicated, and careful monitoring for systemic complications can lead to favorable outcomes, even in complex and prolonged clinical courses.
No takes yet. Share an insight, caveat, or question.
A 2025 study conducted a case report in Fulminant Eosinophilic Myocarditis (n=1). Extracorporeal membrane oxygenation (ECMO) and immunosuppressive therapy was evaluated on Clinical recovery and left ventricular ejection fraction (LVEF). Early use of ECMO and immunosuppressive therapy in a 21-year-old male with fulminant eosinophilic myocarditis led to successful recovery, with left ventricular ejection fraction improving to 50%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: